| | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.164.315 |
| Chemical and physical data | |
| Formula | C12H11N3O |
| Molar mass | 213.240 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
SIB-1757 is a drug used in scientific research which was one of the first compounds developed that acts as a selective antagonist for the metabotropic glutamate receptor subtype mGluR5. [1] It has anti-hyperalgesia effects in animals. [2] SIB-1757 along with other mGluR5 antagonists has been shown to have neuroprotective and hepatoprotective effects, [3] [4] and it is also used to study the role of the mGluR5 receptor in brain development. [5]